Finance

Beta
Lists
300573:SHE
Shenyang Xingqi Pharmaceutical Co Ltd
CN¥36.95
+0.71%
(+0.26) 1D
Jun 5, 3:04:31 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300573...
Open
CN¥37.28
High
CN¥37.81
Low
CN¥36.70
Mkt. cap
13.20B
Avg. vol.
8.44M
Volume
6.81M
Dividend
3.17%
Quarterly dividend
CN¥0.29
Ex-dividend date
May 22, 2026
P/E ratio
17.42
52-wk high
CN¥59.07
52-wk low
CN¥34.37
EPS
CN¥2.12
Shares outstanding
357.32M
No. of employees
2K
Open
CN¥37.28
High
CN¥37.81
Low
CN¥36.70
Mkt. cap
13.20B
Avg. vol.
8.44M
Volume
6.81M
Dividend
3.17%
Quarterly dividend
CN¥0.29
Ex-dividend date
May 22, 2026
P/E ratio
17.42
52-wk high
CN¥59.07
52-wk low
CN¥34.37
EPS
CN¥2.12
Shares outstanding
357.32M
No. of employees
2K
News stories
From sources across the web
About Shenyang Xingqi Pharmaceutical Co Ltd
CEO-
Employees2.4K
FoundedMar 24, 1977
Headquarters-
SectorPharmaceutical industry
Websitesinqi.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
626.60M
740.99M
569.12M
683.34M
Cost of goods sold
125.95M
123.12M
122.47M
122.64M
Cost of revenue
125.95M
123.12M
122.47M
122.64M
Research and development expenses
44.69M
63.36M
70.79M
84.47M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
238.62M
230.42M
264.11M
241.35M
Operating expense
301.91M
286.99M
351.25M
331.32M
Total operating expenses
427.86M
410.12M
473.72M
453.96M
Operating income
198.74M
330.87M
95.41M
229.38M
Other non operating income
-570.29K
-1.22M
475.40K
797.23K
EBT including unusual items
207.17M
304.06M
111.50M
230.12M
EBT excluding unusual items
195.91M
330.73M
93.98M
230.10M
Income tax expense
18.24M
39.98M
14.56M
23.71M
Effective tax rate
8.80%
13.15%
13.05%
10.30%
Other operating expenses
18.37M
-10.95M
20.05M
4.96M
Net income
188.93M
264.08M
96.95M
206.41M
Net profit margin
30.15%
35.64%
17.03%
30.21%
Earnings per share
-
-
-
-
Interest and investment income
672.09K
462.25K
399.40K
408.35K
Interest expense
-1.30M
-1.00M
-631.22K
-481.32K
Net interest expenses
-630.71K
-538.91K
-231.82K
-72.97K
Depreciation and amortization charges
-
-
-
-
EBITDA
221.81M
353.72M
120.67M
254.64M
Gain or loss from assets sale
-74.80K
74.80K
-52.54K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more